Amryt Pharma Share Discussion Threads

[chica1] 24/2/2022 00:02

Whatno.I have told this forum along long time ago that Episalvan (Oleogel-S10) doesn't work.
I have a relative with milder form of Epidermolysis Bullosa and we tried it a number of years ago with no healing effects.I would doubt if it will get FDA approval with Krystal's Genetic based Technology looking very effective.

[whatno] 23/2/2022 21:39

The American market is spiraling down with biotech leading the way. I got sucked into all the hype buying Amryt years ago and as you say these have been a dismal investment (if you can call it that). The one ray of hope was Oleogel but my reading of the constant regulatory delays is that the benefits are so marginal that the EMA can't decide - will the FDA really think any differently?

[bazworth] 22/2/2022 19:45

Why does that comment not surprise me!!

Well done for getting out.

[papillon] 22/2/2022 19:34

AMYT on Nasdaq is definitely going down the plughole and quickly. All those analysts who were forecasting a $40 target on Nasdaq not so long ago were obviously Stark raving bonkers! 🤣


free stock charts from uk.advfn.com

[chica1] 22/2/2022 15:02

Has anyone made money on this share?
Looks like anything that Cathal Friel is involved in is toxic!

[bluechiplet] 15/2/2022 08:44

The FDA decision on Amryt Pharma plc.’s (AMYT) Filsuvez is expected to be announced on February 28. On RTTNews.com

[brummy_git] 04/2/2022 16:19

Justin & I talk about Amryt Pharma (starts 31:30) here in today's Stock Picking video.

www.youtube.com/watch?v=pT7NlRWpmC0&t=2s

[bazworth] 04/2/2022 09:48

III - mine too & happy to hold for the duration!!

Cheers

[cwa1] 04/2/2022 09:38

FWIW my Amryt stock has finally appeared at ii

[richpassi] 04/2/2022 06:44

Veiwing that chart at 6.30am tells me to put down the cuppa and drive into Dagenham and start earning ! Now that's the best investment I ever made !!! Lol

[papillon] 03/2/2022 23:47

What a difference a year makes! The 12 month Nasdaq chart doesn't make for pleasant viewing.
I haven't got any AMYT shares, but I still hold the CVR's, but I'm not optimistic they'll ever be worth anything.


free stock charts from uk.advfn.com

[alphabravo321] 01/2/2022 12:22

So they want to buy back their own shares

[bazworth] 31/1/2022 10:47

I’ve just emailed AMRYT and asked if they can advise further. I doubt they can!!

[cwa1] 31/1/2022 10:38

Still not got mine at ii unfortunately :-(

[bazworth] 31/1/2022 10:36

Anyone still not in receipt of the NASDAQ ADS?

What a nonsense!!

[onceaday] 28/1/2022 16:49

More a case of "hmmm. ... Turning this therapy down with all those terrible images floating around is not gonna make us look good.. Let's get someone else to make the decision!"

[onceaday] 28/1/2022 16:21

The potential $100m windfall is for the paediatric voucher. That will still be awarded on approval, regardless of delay.

[chica1] 28/1/2022 15:36

It would seem the Gene therapy AP103 is not what it promised either.
I see Lara Cutlar (the lady involved in the development of the technology at University College Dublin) that was heading up the project has moved on.

[chica1] 28/1/2022 15:24

I did say along time ago that Episalvan was useless when we tried on a relative.
I wonder how much money have they wasted on this Oleogel-S10 since 2016.

[papillon] 28/1/2022 14:56

But Joe Wiley would lose out, big time, Onceaday because of his large number of CVR's.

Any delay would also delay FDA fast track approval and a potential $100m from it's sale.

[bermudashorts] 28/1/2022 14:54

Exactly so

[onceaday] 28/1/2022 14:38

I would not be surprised to see a similar expert panel announcement from FDA. Although they stated this was not necessary, there have been occasions where they have changed their position later in the approval process.

The ironic thing about all these delays is that it benefits shareholders providing Amryt gets approval eventually. They will save paying out $50M+ if the EMA/FDA CVRs lapse.

[onceaday] 28/1/2022 13:58

Bear in mind the product didn't differentiate from placebo at 90 days and you can see why the CHMP are sitting on the fence. If tbey hadn't decided on a panel, I suspect it would have been a NO.. However, involving the EB community has to tilt the balance in Amryt's favour. Anything, however marginal, must be welcome given the horrendous nature of the condition.

Joe Riley should do the decent thing and extend the CVRs. We have waited a decade for this and now it's being stolen from us.

[bermudashorts] 28/1/2022 13:05

Those CVRs are slipping away in front of our eyes.